Showing results (91-100 of 201) with videos related to
Sort By:
Pageof 21
Asia-Pacific Journal of Clinical Oncology|March 31, 2026
Factors Associated With Long-Term Survivors With Epidermal Growth Factor Receptor Positive Non-Small Cell Lung Cancer Treated With First or Second-Generation Tyrosine Kinase Inhibitors: A Canadian Multi-Center CohortHeather Halperin, Amanda J W Gibson, Ali Hussein, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2016
Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural MesotheliomaLaurent Greillier, Asma Tounsi, Caroline Berenguer-Daizé, et al.Clinical Chemistry and Laboratory Medicine|January 8, 2018
Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluidDiane Frankel, Isabelle Nanni-Metellus, Andrée Robaglia-Schlupp, et al.NPJ Precision Oncology|June 30, 2020
Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordanceLee S Schwartzberg, Hidehito Horinouchi, David Chan, et al.Cancers|January 11, 2022
Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer PatientsColine Montegut, Florian Correard, Emilie Nouguerède, et al.Clinical Lung Cancer|August 16, 2021
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma PatientsJordi Remon, Nicolas Girard, Silvia Novello, et al.Future Oncology (London, England)|June 22, 2021
First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50Renaud Descourt, Christos Chouaid, Maurice Pérol, et al.European Journal of Cancer (Oxford, England : 1990)|August 27, 2014
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: an individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer Lung Cancer Group studies and an independent study validationBaktiar Hasan, Laurent Greillier, Athanasios Pallis, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2021
Impact of care pathway for nursing home residents treated for cancer: ONCO-EHPAD studyAnne-Laure Couderc, Julie Berbis, Géraldine Delalande, et al.Lung Cancer (Amsterdam, Netherlands)|July 4, 2021
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trialArmelle Lavole, Julien Mazieres, Sophie Schneider, et al.Pageof 21